Delivery of Intracellular-Acting Biologics in Pro-Apoptotic Therapies

E-ISSN： 1873-4286|17|3|293-319

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.3, 2011-01, pp. : 293-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Development of Pro-Apoptotic Cancer Therapeutics

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 711-718

Bentham Science Publishers

Access to resources Recommend Favorite

Bortezomib: A New Pro-Apoptotic Agent in Cancer Treatment

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. : 55-67

Bentham Science Publishers

Access to resources Recommend Favorite

Pro-apoptotic effect of fluvastatin on human smooth muscle cells

By Buemi M. Allegra A. Senatore M. Marino D. Medici M.A. Aloisi C. Di Pasquale G. Corica F.

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 201-203

Elsevier

Access to resources Recommend Favorite

Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review

By Bizzarri Mariano Proietti Sara Cucina Alessandra Reiter Russel J

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. : 1483-1496

Informa Healthcare

Access to resources Recommend Favorite

Synthesis, Antiproliferative and Pro-Apoptotic Effects of Nitrostyrenes and Related Compounds in Burkitt's Lymphoma

Medicinal Chemistry, Vol. 14, Iss. 2, 2018-02 ,pp. : 181-199

Bentham Science Publishers

Access to resources Recommend Favorite